- Ohio-based pharmaceutical company Cardinal Health will pay more than $8 million to resolve charges it violated the books, records and internal accounting controls provisions of the Foreign Corrupt Practices Act, the SEC announced Monday.
- Cardinal’s internal accounting controls were insufficient to detect improper payments made by employees of its former Chinese subsidiary, the SEC said.
‘Enforcement 40’ for 2020
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn